Systemic administration of an adenoviral vector expressing PEDF (Ad-PEDF) in a liposomal formulation causes marked suppression of B16-F10 tumour growth, and provoked apoptosis in B16-F10 melanoma cells and inhibited pulmonary metastases [43]. Here, SERPINF1 is linked to neoplasm.